Johnson & Johnson Net debt/EBITDA
Quel est le Net debt/EBITDA de Johnson & Johnson?
Le Net debt/EBITDA de Johnson & Johnson est 1.11
Quelle est la définition de Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA des entreprises dans Health Care secteur sur NYSE par rapport à Johnson & Johnson
Que fait Johnson & Johnson?
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
Entreprises avec net debt/ebitda similaire à Johnson & Johnson
- The Alumasc plc a Net debt/EBITDA de 1.11
- Resources of Australia Ltd a Net debt/EBITDA de 1.11
- Apollo Gold a Net debt/EBITDA de 1.11
- Apollo Gold Corp a Net debt/EBITDA de 1.11
- Avinger Inc a Net debt/EBITDA de 1.11
- CO2 Gro a Net debt/EBITDA de 1.11
- Johnson & Johnson a Net debt/EBITDA de 1.11
- Rock Tech Lithium a Net debt/EBITDA de 1.11
- Canada Jetlines a Net debt/EBITDA de 1.12
- CME Inc a Net debt/EBITDA de 1.12
- CME a Net debt/EBITDA de 1.12
- CME a Net debt/EBITDA de 1.12
- Celestica a Net debt/EBITDA de 1.12